Skip to main content

Table 1 Still not conventional NAFLD treatment targets

From: Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions

Therapeutic target

Pharmacolological treatment

Gut-liver axis

Probiotics[34]

Dyslipidemia/Insulin Resistance

Omega-3 DHA (docosahexaenoic acid)[12]

TNF-α pathway

Pentoxifylline and anti-TNF-α[35]

FXRs pathway

Agonist of the farnesoid X receptor (FXR)[36]